Correlation Between Sartorius Stedim and OSE Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and OSE Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and OSE Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and OSE Pharma SA, you can compare the effects of market volatilities on Sartorius Stedim and OSE Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of OSE Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and OSE Pharma.

Diversification Opportunities for Sartorius Stedim and OSE Pharma

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sartorius and OSE is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and OSE Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OSE Pharma SA and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with OSE Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OSE Pharma SA has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and OSE Pharma go up and down completely randomly.

Pair Corralation between Sartorius Stedim and OSE Pharma

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to under-perform the OSE Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Sartorius Stedim Biotech is 1.79 times less risky than OSE Pharma. The stock trades about -0.01 of its potential returns per unit of risk. The OSE Pharma SA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  560.00  in OSE Pharma SA on November 19, 2024 and sell it today you would earn a total of  138.00  from holding OSE Pharma SA or generate 24.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  OSE Pharma SA

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim sustained solid returns over the last few months and may actually be approaching a breakup point.
OSE Pharma SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days OSE Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Sartorius Stedim and OSE Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and OSE Pharma

The main advantage of trading using opposite Sartorius Stedim and OSE Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, OSE Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OSE Pharma will offset losses from the drop in OSE Pharma's long position.
The idea behind Sartorius Stedim Biotech and OSE Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope